CClinicalTrials.gg
WithdrawnNCT05263128Updated Apr 18, 2024

Turkish Version of the Hand20 Questionnaire With Carpal Tunnel Syndrome

An observational study in Carpal Tunnel Syndrome, sponsored by Hasan Kalyoncu University. Withdrawn. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-04-18.

Sponsored by Hasan Kalyoncu University · Observational

Why this study was withdrawn
The research was left unfinished and was not continued.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
0
Ages
25 Years to 60 Years
Sex
All
01

Study summary

The questionnaire will be investigated by administering the Hand-20 questionnaire and the Boston Carpal Tunnel Syndrome Questionnaire to patients with carpal tunnel syndrome, one week apart.

Read the detailed description

Questionnaires, which are used to express the perception of difficulty and hand functionality during daily living activities of individuals with carpal tunnel syndrome, and most importantly, which are easy to administer, should be preferred in order to plan a patient-specific treatment program with these results. Self-administered questionnaires showing the physical dimension of recovery are effective and sensitive to change.

Hand20 is a short, easy-to-understand and visual questionnaire used to evaluate disorders caused by upper extremity pathologies, developed by Suzuki et al. in 2010 and proven to be valid in upper extremity diseases by Töre et al. In this questionnaire consisting of 20 questions, the answer to each question is graded between 0 and 10 (0: No restrictions, 10: Impossible). The best score is 0, the worst score is 100.

Boston carpal tunnel syndrome questionnaire (BKTSA) will be used to evaluate the functionality level and symptom severity of the patients. In this questionnaire, which consists of 2 parts: symptom severity and functional capacity, a separate average score will be calculated for each part by dividing the total score obtained by the number of questions. An increased score indicates decreased functional capacity and increased symptom severity.

02

Conditions studied

  • Carpal Tunnel Syndrome

Keywords

  • Carpal tunnel syndrome
03

In context

Carpal Tunnel Syndrome

589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Hasan Kalyoncu University is the lead sponsor of 161 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Individuals diagnosed with carpal tunnel syndrome

Inclusion criteria

  • Patients aged 25-60 years
  • Patients diagnosed with carpal tunnel
  • Patients who volunteered for treatment

Exclusion criteria

Exclusion Criteria:

  • Patients who do not agree to volunteer
  • Patients who have undergone surgery from the wrist region
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
0 participants (actual)
Target follow-up
7 Days
Patient registry
Yes

Groups and cohorts

  • Boston carpal tunnel syndrome questionnaire

    Other: Investigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome

  • Hand-20 questionnaire

    Other: Investigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome

Interventions

  • OtherInvestigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome

    To investigate the validity and reliability of the Hand-20 questionnaire used in individuals with upper extremity disease by comparing it with the Boston carpal tunnel syndrome questionnaire in individuals with carpal tunnel syndrome in Turkey

06

What researchers measure

Primary outcomes

  1. Investigation of the Validity of the Hand-20 Questionnaire in Individuals with Carpal Tunnel Syndrome

    Time frame: 1 week apart

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05263128
Lead sponsor
Hasan Kalyoncu University
Responsible party
Neslihan Torun (Investigator, Hasan Kalyoncu University) — Principal investigator
First posted
Mar 2, 2022
Start date
Aug 1, 2022
Primary completion
May 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Apr 18, 2024

Study contacts

Aysenur Tuncer, PhD
study director · Hasan Kalyoncu University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion